semaglutide oral approval FDA Approves Semaglutide: First GLP-1 Weight Loss Pill Clinical Capsules: Semaglutide Becomes the

Why women need lower doses Biological differences: Smaller average body size Different hormone profiles More sensitive to some peptides Better response at lower doses often General rule: Start 20-30% lower than male doses Women: 150-200mcg vs Men: 200-300mcg (GH peptides) Titrate based on response More isn't better for women Hormone cycle considerations (perimenopause) If still menstruating: GH peptides: Use consistently throughout cycle Weight loss peptides: May work better in follicular phase (days 1-14) Some women dose higher during luteal phase (more resistant) Track response across full cycle Post-menopause: No cycle to consider Consistent dosing easier More predictable results Age-specific dosing Women 40-50 (perimenopause): Start conservative Body still producing some hormones Lower doses effective Women 50-60 (menopause): Standard doses appropriate Need more GH replacement Can titrate higher if needed Women 60-70+: Start very low Increase slowly More sensitive to side effects Benefits still significant Safety considerations for women over 40 Special precautions for this demographic

Theyve been shown to help people lose a significant amount of weight when combined with diet and exercise

Early dosing can cause your body to experience a rapid rise in appetite suppression, which feels overwhelming rather than sustainable

Our retention periods are always based on legal requirements and a balance of your rights and expectations with what is useful and necessary for fulfilling our purposes

(HIMS) Company Profile Hims (NYSE: HIMS) runs a telehealth platform

Matcha, packed with antioxidants, helps soothe and protect the skin from environmental stressors, while Glutathione works to visibly brighten dullness and promote a more radiant, even-toned complexion